Insider Transactions in Q2 2025 at Outset Medical, Inc. (OM)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2025
|
Marc Nash SVP Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
29,676
+40.75%
|
-
|
|
Jun 10
2025
|
Renee Gaeta Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
131,425
+50.0%
|
-
|
|
Jun 10
2025
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
65,103
+34.57%
|
-
|
|
Jun 10
2025
|
John L. Brottem General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
35,993
+43.23%
|
-
|
|
Jun 02
2025
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,983
+42.46%
|
-
|
|
Jun 02
2025
|
Patrick T Hackett Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,983
+8.62%
|
-
|
|
Jun 02
2025
|
Brent D. Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,983
+33.48%
|
-
|
|
Jun 02
2025
|
Kevin C Oboyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,983
+27.14%
|
-
|
|
Jun 02
2025
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,983
+42.41%
|
-
|
|
Jun 02
2025
|
D Keith Grossman Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,983
+39.23%
|
-
|
|
May 15
2025
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
584
-3.5%
|
$9,928
$17.81 P/Share
|
|
May 15
2025
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
396
-3.39%
|
$6,732
$17.82 P/Share
|
|
May 15
2025
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
252
-1.84%
|
$4,284
$17.82 P/Share
|
|
May 15
2025
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
935
-1.58%
|
$15,895
$17.8 P/Share
|
|
May 14
2025
|
Kevin C Oboyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,135
+50.0%
|
-
|